Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age

被引：0
|
作者：
Raffaele Addeo
Vincenzo Faiola
Rosario Guarrasi
Liliana Montella
Bruno Vincenzi
Elena Capasso
Gregorio Cennamo
Maria Saveria Rotundo
Pierosandro Tagliaferri
Michele Caraglia
Salvatore Del Prete
机构：
[1] “S.Giovanni di Dio” Hospital,Oncology Unit, U.O.C. Oncology
[2] Campus Biomedico University,Section of Oncology
[3] University Magna Grǽcia of Catanzaro and Oncology Center “T. Campanella”,Department of Experimental and Clinical Medicine
[4] National Institute of Tumours of Naples,Experimental Pharmacology Unit, INT Pascale
[5] Via Mariano Semmola,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
Metastatic breast cancer; Vinorelbine; Liposomal pegylated doxorubicin; QoL; Elderly patients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age
    Addeo, Raffaele
    Faiola, Vincenzo
    Guarrasi, Rosario
    Montella, Liliana
    Vincenzi, Bruno
    Capasso, Elena
    Cennamo, Gregorio
    Rotundo, Maria Saveria
    Tagliaferri, Pierosandro
    Caraglia, Michele
    Del Prete, Salvatore
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 285 - 292
  • [2] Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer
    Mlineritsch, Brigitte
    Schabel-Moser, Renate
    Andel, Johannes
    Fridrik, Michael
    Moik, Martin
    Mayer, Peter
    Russ, Gudrun
    Rass, Christof
    Greil, Richard
    ONKOLOGIE, 2009, 32 (1-2): : 18 - 24
  • [3] Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in elderly metastatic breast cancer patients
    Dufour, P. R.
    Rousseau, F.
    Meyer, N.
    Delozier, T.
    Serin, D.
    Nabet, M.
    Djafari, L.
    Kurtz, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Pegylated Liposomal Doxorubicin (Caelyx®) and Oral Vinorelbine in First-Line Metastatic Breast Cancer Patients Previously Treated with Anthracyclines
    Livi, L.
    Meattini, I.
    Scotti, V.
    Cardillo, C. De Luca
    Galardi, A.
    Iermano, C.
    Sanchez, L.
    Nori, J.
    Mangoni, M.
    Franzese, C.
    Orzalesi, L.
    Bertocci, S.
    Agresti, B.
    Masoni, T.
    Bianchi, S.
    Cataliotti, L.
    Biti, G.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (03) : 158 - 162
  • [5] Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in older metastatic breast cancer patients
    Kurtz, J. E.
    Rousseau, F.
    Meyer, N.
    Delozier, T.
    Serin, D.
    Nabet, M.
    Djafari, L.
    Dufour, P.
    ONCOLOGY, 2007, 73 (3-4) : 210 - 214
  • [6] Combination of docetaxel and doxorubicin as first-line chemotherapy in metastatic breast cancer
    Baltali, E
    Özisik, Y
    Güler, N
    Firat, D
    Altundag, K
    TUMORI, 2001, 87 (01) : 18 - 19
  • [7] Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older
    Vogel, C
    O'Rourke, M
    Winer, E
    Hochster, H
    Chang, A
    Adamkiewicz, B
    White, R
    McGuirt, C
    ANNALS OF ONCOLOGY, 1999, 10 (04) : 397 - 402
  • [8] Phase II study of weekly pegylated liposomal doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer.
    Holmes, F
    Blum, JL
    Kruger, S
    Ratnam, S
    Liu, L
    Boehm, KA
    Asmar, L
    O'Shaughnessy, JA
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S130 - S130
  • [9] Weekly paclitaxel and pegylated liposomal doxorubicin (PLD) as first-line therapy in metastatic breast cancer
    Valerio, M. R.
    Fulfaro, F.
    Cicero, G.
    Rinaldi, G.
    Maiorana, O.
    Spinnato, F.
    Intrivici, C.
    Crosta, A.
    Scibilia, C.
    Pizzo, T.
    Vanella, P.
    Gebbia, N.
    ANNALS OF ONCOLOGY, 2006, 17 : VII147 - VII147
  • [10] Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified
    Green, H.
    Stal, O.
    Bachmeier, K.
    Backlund, L. M.
    Carlsson, L.
    Hansen, J.
    Lagerlund, M.
    Norberg, B.
    Franzen, A.
    Aleskog, A.
    Malmstrom, A.
    CANCER LETTERS, 2011, 313 (02) : 145 - 153
12345